Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : GENI: GenesisIntermedia.com Inc -- Ignore unavailable to you. Want to Upgrade?

To: afrayem onigwecher who wrote (10)	4/25/2001 9:37:37 AM
From: Sir Auric Goldfinger	Read Replies (1) \| Respond to of 574

Weak, Isaac, very weak: "GenesisIntermedia Issues Letter to Shareholders 2001-04-25 09:14 (New York) Business Editors LOS ANGELES--(BUSINESS WIRE)--April 25, 2001-- GenesisIntermedia.com Inc. (Nasdaq/NM: GENI) (Frankfurt: GIA) today announced that it has issued the following letter to its shareholders: Dear Fellow GENI stockholder: It is my pleasure to report to you that we are continuing to implement strategies to grow Centerlinq, Car Rental Direct and Genesis Media Group, as well as identify new opportunities for expansion. We envision growing the company's operations, thus increasing shareholder value, through capitalizing on acquisition opportunities and through the continued practice of entering into strategic alliances and joint ventures that help gain market share, new resources and expanded competencies for GENI and subsidiaries. We want to be able to continue to provide you with a healthy share price. We believe the best way to do this is by following through with our initiatives to build Centerlinq, Car Rental Direct, Genesis Media Group and future acquisitions. Recent cash infusions into GENI and our subsidiaries will be used for this purpose. I would also like to thank both our individual and institutional investors for your continued support of GENI. Companies like ours that are striving to create value for their shareholders, and for consumers and the business community, need to stay focused on long-term vision in order to achieve their goals. Lately, there have been a number of companies that have had to turn part of their attention away from growth strategies in order to combat increasingly heavy pressure from "short selling." In our case, according to reports published by Bloomberg L.P., out of 21 million GENI shares outstanding, there was a total short position of approximately 4.6 million shares. That is why we are asking for your help. The Short Selling Process and Its Effects One thing to remember about short selling; those who are doing it do NOT own the stock. Short sellers are not aligned with the interests of the company or of its shareholders. They borrow your stock from your broker, and need to return it at a later date. If the stock price goes down, the short sellers then buy stock in the market at the lower price, and return the stock they borrowed from the broker -- that's how the short sellers make a profit. By selling first and buying later, short sellers benefit from stock prices going down instead of up. This makes their interest in our company directly opposite from what most of our stockholders want -- i.e. for the price to go up. We are all working toward increased share price, while short sellers are looking for a decrease. If there is a lot of short selling, the supply of our shares may exceed demand for our shares, causing the stock price to go down. Short sellers bet on that. In effect, short sellers could make money by selling enough stock short to artificially increase the volume of selling, which then drives down the market price. Short Sellers Borrow The Stock From You Short sellers borrow the stock from shareholders, whether or not the shareholders are aware of it. If your shares are registered in your broker's name (commonly referred to as "street name") instead of your name, or if your shares are held in a margin account, your broker might have loaned your shares of GENI or other investment to the short sellers. When shares are held in street name, the broker is the legal owner of record and can loan your stock to anyone without your permission. Many companies currently in the marketplace are experiencing a high volume of short selling. Unfortunately, we are no exception. The amount of short selling compared to the trading volume in our stock is unusually high. A large short position, like the one that currently exists for GENI stock, has the ability to significantly push down the price of a stock. Taking Control of the Short Sellers Short sales occur when traders borrow stock from brokers that is either registered in "street name" or held in margin accounts. The less the inventory of stock held in street name and margin accounts, the less shares available to borrow, thus reducing the likelihood of short selling. If enough stock is taken out of street name and margin accounts, short sellers will have difficulty maintaining the current volume of short sales. As fellow GENI shareholders, we are asking that you help secure your investment. Contact your broker and have your shares taken out of street name or put into a cash account. Your ability to deal with your investment as you want does not change. You still own the stock, and you still make decisions regarding your investment. The only change would be that your shares would not be held in your broker's name anymore, and they would be in a cash account. By doing this, a short seller would not be able to borrow your stock for short sales without your permission. Also, when your stock is held in a margin account, brokers can loan it out. Transferring your shares into a cash account is an easy way to safeguard your investment. There is no disadvantage for stockholders who have their investments registered in their own names or held in cash accounts. There will possibly be some administrative functions that you would need to carry out to effect this change, such as paperwork and nominal charges in conjunction with re-registering or moving your shares. When you want to sell, you would have to send your broker instructions to move the stock back into street name or into a margin account, and the broker may ask you to sign some transfer documents. Overall, though, it is a small price to pay for relieving the heavy short selling pressure on the stock that you own. We're asking our shareholder base to respond immediately. Short selling works to all shareholders' detriment, and we would like to see an immediate reduction in the short selling pressure on GENI stock. We intend to work with our transfer agent and participating brokers to make the process of re-registering your shares or moving them into cash accounts now as quick and easy as practicable. If you have any questions about this process, please call Robert Bleckman at GenesisIntermedia, 818/902-4397, for assistance. Again, we are looking forward to maintaining our shareholders as partners in growth. We greatly appreciate your support and your belief in us as we build a company that creates value for shareholders and value for consumers and business. Sincerely, Ramy El-Batrawi Chairman and CEO This document contains certain forward-looking statements that are subject to risks and uncertainties. For such statements, GenesisIntermedia.com claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors discussed in GenesisIntermedia.com's Annual Report on Form 10(K) for the year ended December 31, 2000 filed with the Securities and Exchange Commission. The contents herein shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state or jurisdiction. --30--rs/la* CONTACT: GenesisIntermedia.com Inc. Robert Bleckman, 818/902-4397 robertb@genesisintermedia.com KEYWORD: CALIFORNIA INDUSTRY KEYWORD: ADVERTISING/MARKETING AUTOMOTIVE E-COMMERCE INTERNET RETAIL Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com

To: afrayem onigwecher who wrote (10)	4/25/2001 9:08:13 PM
From: Sir Auric Goldfinger	Read Replies (4) \| Respond to of 574

So Isaac is your GENI chairman affiliated w/ any of your offshore holding Cos? Short swing rule applies! "The hedge fund group owns 19 percent, or about 2.1 million of NetSol's 11 million outstanding shares. Shareholders who own more than 10 percent of a company are prohibited from profiting from ``short swing'' trades in which shares are bought and sold within six months. The law, based on Section 16(b) of the Securities Exchange Act of 1934, is intended to prevent improper insider trading. It requires violators to return their trading profits to the company. Blue Water Partners LLC, the funds' general partner, is managed by Jonathan Iseson of Manhasset, New York, who signed a settlement agreement with NetSol. He wasn't immediately available for comment. Insider & restricted shareholder transactions reported over the last year Date Who Shares Stock Transaction 29-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 26,000 GENI Purchased at $7.56/Share. Cost of $196,560. 28-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 36,350 GENI Purchased at $7.56/Share. Cost of $274,806. 27-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 36,500 GENI Purchased at $7.54/Share. Cost of $275,210. 26-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 17,185 GENI Purchased at $7.32/Share. Cost of $125,794. 23-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 21,000 GENI Purchased at $7.31/Share. Cost of $153,510. 22-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 129,600 GENI Purchased at $7.16/Share. Cost of $927,936. 21-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 19,200 GENI Purchased at $21.98/Share. Cost of $422,016. 20-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 12,400 GENI Purchased at $22.26/Share. Cost of $276,024. 19-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 15,000 GENI Purchased at $22.19/Share. Cost of $332,850. 16-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 10,000 GENI Purchased at $22.19/Share. Cost of $221,900. 15-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 70,000 GENI Purchased at $22.19/Share. Cost of $1,553,300. 13-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 2,100 GENI Sold at $23.38/Share. Proceeds of $49,098. 12-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 20,600 GENI Sold at $23.53/Share. Proceeds of $484,718. 7-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 20,000 GENI Sold at $21.56/Share. Proceeds of $431,200. 6-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 30,000 GENI Sold at $17.00/Share. Proceeds of $510,000. 2-Mar-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 10,000 GENI Sold at $21.41/Share. Proceeds of $214,100. 27-Feb-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 2,000 GENI Sold at $20.56/Share. Proceeds of $41,120. 20-Feb-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 30,000 GENI Purchased at $18.83/Share. Cost of $564,900. 16-Feb-01 ELBATRAWI, RAMY Y Chairman of the Board, Director, Chief Executive Officer, 10% Beneficial Owner 1,600 GENI Purchased at $19.13/Share. Cost of $30,608. 15-Feb-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 3,250 GENI Sold at $18.94/Share. Proceeds of $61,555. 15-Feb-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 32,500 GENI Purchased at $18.94/Share. Cost of $615,550. 14-Feb-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 50,000 GENI Sold at $17.16/Share. Proceeds of $858,000. 14-Feb-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 19,500 GENI Purchased at $18.96/Share. Cost of $369,720. 9-Feb-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 50,000 GENI Purchased at $19.26/Share. Cost of $963,000. 5-Feb-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 50,900 GENI Purchased at $18.72/Share. Cost of $952,848. 31-Jan-01 ELBATRAWI, RAMY Y Chairman of the Board, Director, Chief Executive Officer, 10% Beneficial Owner 2,100 GENI Purchased at $19.56/Share. Cost of $41,076. 30-Jan-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 30,000 GENI Sold at $17.00/Share. Proceeds of $510,000. 25-Jan-01 ELBATRAWI, RAMY Y Chairman of the Board, Director, Chief Executive Officer, 10% Beneficial Owner 1,000 GENI Purchased at $19.31/Share. Cost of $19,310. 19-Jan-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 100 GENI Purchased at $19.88/Share. Cost of $1,988. 8-Jan-01 ELBATRAWI, RAMY Y Chairman of the Board, Director, Chief Executive Officer, 10% Beneficial Owner 38,900 GENI Purchased at $17.79/Share. Cost of $692,031. 5-Jan-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 55,900 GENI Purchased at $16.75/Share. Cost of $936,325. 4-Jan-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 9,300 GENI Purchased at $17.13/Share. Cost of $159,309. 3-Jan-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 42,100 GENI Purchased at $16.99/Share. Cost of $715,279. 2-Jan-01 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 79,600 GENI Purchased at $15.53/Share. Cost of $1,236,188. 26-Dec-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 55,000 GENI Purchased at $17.04/Share. Cost of $937,200. 19-Dec-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 45,643 GENI Purchased at $17.87/Share. Cost of $815,640. 18-Dec-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 72,800 GENI Purchased at $18.06/Share. Cost of $1,314,768. 15-Dec-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 28,000 GENI Purchased at $17.87/Share. Cost of $500,360. 12-Dec-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 50,000 GENI Purchased at $17.88/Share. Cost of $894,000. 6-Dec-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 75,000 GENI Purchased at $18.06/Share. Cost of $1,354,500. 29-Nov-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 30,000 GENI Purchased at $18.06/Share. Cost of $541,800. 21-Nov-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 40,000 GENI Purchased at $18.03/Share. Cost of $721,200. 17-Nov-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 40,000 GENI Purchased at $18.06/Share. Cost of $722,400. 1-Nov-00 ELBATRAWI, RAMY Y Chairman of the Board, Director, Chief Executive Officer, 10% Beneficial Owner 100,000 GENI Purchased at $15.31/Share. Cost of $1,531,000. 24-Oct-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 90,000 GENI Purchased at $15.00/Share. Cost of $1,350,000. 23-Oct-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 110,000 GENI Purchased at $15.06/Share. Cost of $1,656,600. 6-Oct-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 90,000 GENI Purchased at $15.00/Share. Cost of $1,350,000. 18-Sep-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 40,000 GENI Purchased at $15.06/Share. Cost of $602,400. 15-Sep-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 25,000 GENI Purchased at $15.06/Share. Cost of $376,500. 12-Sep-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 9,500 GENI Purchased at $15.06/Share. Cost of $143,070. 11-Sep-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 26,500 GENI Purchased at $15.11/Share. Cost of $400,415. 8-Sep-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 25,000 GENI Purchased at $15.80/Share. Cost of $395,000. 5-Sep-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 15,000 GENI Purchased at $15.19/Share. Cost of $227,850. 1-Sep-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 37,500 GENI Purchased at $15.56/Share. Cost of $583,500. 30-Aug-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 22,000 GENI Purchased at $15.06/Share. Cost of $331,320. 29-Aug-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 34,500 GENI Purchased at $15.06/Share. Cost of $519,570. 29-Aug-00 ELBATRAWI, RAMY Y Chairman of the Board, Director, Chief Executive Officer, 10% Beneficial Owner 1,000 GENI Purchased at $15.25/Share. Cost of $15,250. 23-Aug-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 9,100 GENI Purchased at $15.06/Share. Cost of $137,046. 22-Aug-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 12,600 GENI Purchased at $15.06/Share. Cost of $189,756. 18-Aug-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 3,700 GENI Purchased at $15.16/Share. Cost of $56,092. 11-Aug-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 2,720 GENI Purchased at $15.11/Share. Cost of $41,099. 10-Aug-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 60,000 GENI Purchased at $13.33/Share. Cost of $799,800. 10-Aug-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 28,500 GENI Purchased at $15.12/Share. Cost of $430,920. 8-Aug-00 ULTIMATE HOLDINGS LTD 10% Beneficial Owner 1,600 GENI Purchased at $15.16/Share. Cost of $24,256. 21-Jul-00 ELBATRAWI, RAMY Y Chairman of the Board, Director, Chief Executive Officer, 10% Beneficial Owner 2,500 GENI Purchased at $15.25/Share. Cost of $38,125. 20-Jul-00 ELBATRAWI, RAMY Y Chairman of the Board, Director, Chief Executive Officer, 10% Beneficial Owner 10,000 GENI Purchased at $15.91/Share. Cost of $159,100. 22-Jun-00 DINKEL, CRAIG T Chief Operating Officer 6,000 GENI Sold at $15.14/Share. Proceeds of $90,840. 19-Jun-00 DINKEL, CRAIG T Chief Operating Officer 30,000 GENI Proposed Sale (Form 144). Estimated proceeds of $450,000. 19-Jun-00 ELBATRAWI, RAMY Y Chairman of the Board, Director, Chief Executive Officer, 10% Beneficial Owner 100,000 GENI Purchased at $15.25/Share. Cost of $1,525,000. 13-Jun-00 KAWASUGI, JEFFREY M Shareholder 300 GENI Proposed Sale (Form 144). Estimated proceeds of $4,500. 9-Jun-00 WEBER, STEPHEN A Director 0 GENI Initial Direct Holdings Statement 8-May-00 COSTA, MICHAEL F Vice President 10,000 GENI Proposed Sale (Form 144). Estimated proceeds of $157,500. 28-Apr-00 ELBATRAWI, RAMY Y Chairman of the Board, Director, Chief Executive Officer, 10% Beneficial Owner 19,000 GENI Purchased at $16.24/Share. Cost of $308,560. 13-Apr-00 ELBATRAWI, RAMY Y Chairman of the Board, Director, Chief Executive Officer, 10% Beneficial Owner 75,000 GENI Purchased at $18.15/Share. Cost of $1,361,250.